Expands collaborative drug therapy management by pharmacists; makes permanent certain provisions relating to authorizing pharmacists to perform collaborative drug therapy management with physicians in certain settings.
STATE OF NEW YORK
________________________________________________________________________
11334
IN ASSEMBLY
May 11, 2026
___________
Introduced by COMMITTEE ON RULES -- (at request of M. of A. McDonald) --
read once and referred to the Committee on Higher Education
AN ACT to amend the education law, in relation to expanding collabora-
tive drug therapy management; and to amend chapter 21 of the laws of
2011 amending the education law relating to authorizing pharmacists to
perform collaborative drug therapy management with physicians in
certain settings, in relation to the effectiveness thereof
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Paragraph d of subdivision 1 and subdivision 4 of section
2 6801-a of the education law, as amended by chapter 238 of the laws of
3 2015, are amended to read as follows:
4 d. "Facility" shall mean: (i) a teaching hospital or general hospital,
5 including any diagnostic center, treatment center, or hospital-based
6 outpatient department as defined in section twenty-eight hundred one of
7 the public health law; [or] (ii) a nursing home [with an on-site pharma-
8 cy staffed by a licensed pharmacist]; (iii) a physician practice; or
9 (iv) a facility licensed, certified, or otherwise authorized pursuant to
10 article thirty-one or article thirty-two of the mental hygiene law,
11 provided, however, for the purposes of this section the term "facility"
12 shall not include dental clinics, dental dispensaries, residential
13 health care facilities and rehabilitation centers.
14 For the purposes of this section, a "teaching hospital" shall mean a
15 hospital licensed pursuant to article twenty-eight of the public health
16 law that is eligible to receive direct or indirect graduate medical
17 education payments pursuant to article twenty-eight of the public health
18 law.
19 4. The existence of a written agreement or protocol on collaborative
20 drug therapy management and the patient's right to choose to not partic-
21 ipate in collaborative drug therapy management shall be disclosed to any
22 patient who is eligible to receive collaborative drug therapy manage-
23 ment. Collaborative drug therapy management shall not be utilized unless
24 the patient or the patient's authorized representative consents, in
25 writing, to such management. If the patient or the patient's authorized
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD15789-01-6
A. 11334 2
1 representative consents, it shall be noted on the patient's medical
2 record. If the patient or the patient's authorized representative who
3 consented to collaborative drug therapy management chooses to no longer
4 participate in such management, at any time, it shall be noted on the
5 patient's medical record. Patient consent to participate in collabora-
6 tive drug therapy management may be obtained through the same process a
7 facility currently utilizes to receive general written consent from
8 patients to receive health care services. In addition, the existence of
9 the written agreement or protocol and the patient's consent to such
10 management shall be disclosed to the patient's primary physician and any
11 other treating physician or healthcare provider.
12 § 2. Section 5 of chapter 21 of the laws of 2011, amending the educa-
13 tion law relating to authorizing pharmacists to perform collaborative
14 drug therapy management with physicians in certain settings, as amended
15 by section 2 of part P of chapter 57 of the laws of 2024, is amended to
16 read as follows:
17 § 5. This act shall take effect on the one hundred twentieth day after
18 it shall have become a law[, provided, however, that the provisions of
19 sections two, three, and four of this act shall expire and be deemed
20 repealed July 1, 2026]; provided, however, that the amendments to subdi-
21 vision 1 of section 6801 of the education law made by section one of
22 this act shall be subject to the expiration and reversion of such subdi-
23 vision pursuant to section 8 of chapter 563 of the laws of 2008, when
24 upon such date the provisions of section one-a of this act shall take
25 effect; provided, further, that effective immediately, the addition,
26 amendment and/or repeal of any rule or regulation necessary for the
27 implementation of this act on its effective date are authorized and
28 directed to be made and completed on or before such effective date.
29 § 3. This act shall take effect immediately.
